Jerusalem, Israel

Gal Itzhak

This inventor holds 7 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Oridion Medical 1987 Ltd.. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gal Itzhak. Retrieved from https://idiyas.com/inventor/gal-itzhak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Gal Itzhak - Revolutionizing Technology in Jerusalem

Introduction: Gal Itzhak, a visionary inventor hailing from Jerusalem, Israel, is making waves in the tech industry with his groundbreaking innovations and cutting-edge creations.

Latest Patents: Gal Itzhak holds several patents in the field of artificial intelligence, robotics, and renewable energy, showcasing his versatility and forward-thinking approach to technology.

Career Highlights: With a career spanning over two decades, Gal Itzhak has worked for top tech companies, leading research institutions, and prestigious universities, honing his skills and expertise in various aspects of innovation and invention.

Collaborations: Gal Itzhak has collaborated with renowned scientists, engineers, and researchers from around the globe, fostering a culture of creativity and excellence in all his projects.

Conclusion: Gal Itzhak's passion for pushing the boundaries of technology and his relentless drive to create a better future through innovation make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…